首页> 外国专利> FORMULATION FOR DELIVERING LIPID-LOWERING DRUGS BY ORAL TRANSMUCOSAL ADMINISTRATION.

FORMULATION FOR DELIVERING LIPID-LOWERING DRUGS BY ORAL TRANSMUCOSAL ADMINISTRATION.

机译:通过口服经皮给药管理降脂药物的配方。

摘要

The invention relates to a formulation for delivering at least one lipid-lowering active principle by oral transmucosal administration, preferably of the statin family, said formulation including said active principle in the form of a base or a salt, a hydroalcoholic solution containing water and ethanol with an alcoholic content of at least 30% ABW, and optionally a pH correcting agent and/or an anti-oxidiser, said active principle being at a stable and complete dissolution state in the hydroalcoholic solution. The invention also relates to a method for preparing said formulation and to the use thereof, preferably in a single-dose packaging, for treating and preventing hyperlipemia and/or cardiovascular disorders.
机译:本发明涉及通过口服经粘膜给药,优选他汀类的至少一种降脂活性成分的制剂,所述制剂包括碱或盐形式的所述活性成分,含有水和乙醇的水醇溶液具有至少30%ABW的酒精含量和任选的pH校正剂和/或抗氧化剂,所述活性成分在水醇溶液中处于稳定且完全溶解的状态。本发明还涉及用于制备所述制剂的方法及其用途,优选在单剂量包装中用于治疗和预防高脂血症和/或心血管疾病的用途。

著录项

  • 公开/公告号MX2011006797A

    专利类型

  • 公开/公告日2011-09-06

    原文格式PDF

  • 申请/专利权人 MARC MAURY;

    申请/专利号MX20110006797

  • 发明设计人 PHILIPPE PEROVITCH;MARC MAURY;

    申请日2009-12-17

  • 分类号A61K9;A61K31/19;A61K31/216;A61K31/22;A61K31/351;A61K31/397;A61K31/40;A61K31/404;A61K31/505;A61K47/10;A61P3/06;A61P9;

  • 国家 MX

  • 入库时间 2022-08-21 18:05:17

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号